The conservative view: is it necessary to implant a stent into the dopamine transporter?

Publisher： John Wiley & Sons Inc

E-ISSN： 1476-5381|172|19|4775-4778

ISSN： 0007-1188

Source： BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol.172, Iss.19, 2015-10, pp. : 4775-4778

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dopamine transporter binding in social anxiety disorder: the effect of treatment with escitalopram

By Warwick J.  

Metabolic Brain Disease, Vol. 27, Iss. 2, 2012-06 ,pp. : 151-158

Springer Publishing Company

Access to resources Recommend Favorite

Uric acid relates to dopamine transporter availability in Parkinson's disease

By  

ACTA NEUROLOGICA SCANDINAVICA (ELECTRONIC), Vol. 131, Iss. 2, 2015-02 ,pp. : 127-131

John Wiley & Sons Inc

Access to resources Recommend Favorite

Metaiodobenzylguanidine Myocardial Scintigraphy Identifies Premotor Parkinson's Disease During a Negative Dopamine Transporter Scan

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 63, Iss. 11, 2015-11 ,pp. : 2428-2430

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genetic Analysis of Polymorphisms in Dopamine Receptor and Transporter Genes for Association with Smoking among Cancer Patients

By  

European Addiction Research, Vol. 19, Iss. 2, 2012-11 ,pp. : 105-111

Karger

Access to resources Recommend Favorite